https://www.pharmanow.live/latest-news/medicus-pharma-submits-seamless-phase-2b3-protocol-fda-teverelix-advanced-prostate-cancer 2026-09-29T22:13:13+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Medicus Pharma Submits Phase 2b/3 Teverelix Protocol to FDA Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/e23e6d43-56bf-4046-8d48-f518b33bf0ad.png https://www.pharmanow.live/latest-news/fresenius-kabi-fda-warning-letter-aseptic-processing-melrose-park-2026 2026-09-29T22:36:07+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Fresenius Kabi Receives FDA Warning Letter After Aseptic Processing Investigation Failures at Melrose Park Facility FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/730da0e9-6e7c-4580-9d4b-9165d4c9f685.png https://www.pharmanow.live/latest-news/celmade-fda-warning-letter-unapproved-botulinum-toxin-2026 2026-09-29T22:34:17+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Celmade Receives FDA Warning Letter for Unapproved Injectable Botulinum Toxin Sales into U.S. Celmade https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/519e0241-9eba-4645-91f1-3a5101a76458.png https://www.pharmanow.live/latest-news/bentley-laboratories-fda-cgmp-warning-letter-2026 2026-09-29T22:33:38+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Bentley Laboratories Receives FDA CGMP Warning Letter Citing OOS Investigation Failures and Unapproved Drugs https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/dfc8dccc-6adc-4825-aa2c-f9793f6e4dcb.png https://www.pharmanow.live/latest-news/akums-dcgi-approval-colchicine-cardiovascular-india-first 2026-09-29T22:18:22+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Akums Gains DCGI Approval for Colchicine in Cardiovascular Indication, a First in India Akums https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/c8897923-2262-4021-80af-6c39e3583d1c.png https://www.pharmanow.live/latest-news/pfizer-45-oncology-studies-esmo-2025-madrid 2026-09-29T22:17:38+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Pfizer Takes 45 Oncology Studies to ESMO 2025 Congress in Madrid Across Oral and Poster Sessions Pfizer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/3dff829d-d25a-4a9f-b5b2-eeb4fe5ca7db.png https://www.pharmanow.live/latest-news/abbvie-fda-approval-juvmo-parkinsons-disease-d1-d5-agonist 2026-09-29T22:15:33+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 AbbVie Wins FDA Approval for JUVMO in Parkinson's Disease AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/139145a9-2925-4f51-a1f3-1e47cd2b69c0.png https://www.pharmanow.live/latest-news/phathom-pharmaceuticals-initiates-phase-3-vonoprazan-as-needed-nerd 2026-09-29T22:20:50+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Phathom Launches Phase 3 Vonoprazan Trial for GERD Phathom https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/1b5aa880-3ae6-4c52-8081-d9e4df7d7798.png https://www.pharmanow.live/latest-news/moleculin-biotech-completes-part-a-enrollment-miracle-trial-aml-q1-2027 2026-09-29T22:24:50+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Moleculin Biotech Achieves Full Part A Enrollment in Phase 2/3 AML MIRACLE Trial Moleculin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/2ed61cb0-706c-4cd6-9e19-68a9927f43c4.png https://www.pharmanow.live/latest-news/epicur-pharma-fda-warning-letter-misbranded-compounded-animal-drugs-2026 2026-09-29T22:33:05+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Epicur Pharma Receives FDA Warning Letter Over Misbranded Compounded Animal Drug Claims Epicur https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/18f1378f-c5ab-4d25-906b-f87274460e18.png https://www.pharmanow.live/latest-news/abbvie-signs-ai-collaboration-valkai-accelerate-clinical-development-timelines 2026-09-29T22:23:16+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 AbbVie Partners With Valkai to Accelerate Clinical Development AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/7692a0cd-bf6d-4af7-95f3-199c99cc7dc0.png https://www.pharmanow.live/latest-news/propanc-biopharma-gmp-manufacture-regulatory-phase-1b-prp-trial-2027 2026-09-29T22:28:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Propanc Biopharma Advances GMP Manufacture and Regulatory Workstreams Propanc https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/291290b9-efbb-45f6-b0db-1dd38daea44c.png https://www.pharmanow.live/latest-news/newamsterdam-pharma-spinoza-trial-first-participant-preclinical-alzheimers 2026-09-29T22:25:47+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial for Preclinical Alzheimer's Disease NewAmsterdam https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/f2f9b3e9-02d7-4741-9828-35ea7720ad18.png https://www.pharmanow.live/latest-news/fibrobiologics-secures-european-patent-fibroblast-conditioning-spinal-disc-regeneration 2026-09-29T22:27:18+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 FibroBiologics Secures European Patent for Fibroblast Conditioning Methods Covering Spinal Disc Regeneration FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/6cdfa044-74bf-48de-b049-de79f1c15076.png https://www.pharmanow.live/latest-news/kellin-chemicals-adulteration-designation-fda-inspection-refusal-zhangjiagang 2026-09-29T22:30:31+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Kellin Chemicals Gains Adulteration Designation After Refusing FDA Facility Inspection in Zhangjiagang Kellin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/31bad8e3-e646-476c-bc1c-c967ee472f36.png https://www.pharmanow.live/latest-news/curia-new-york-fda-warning-letter-undocumented-chromatographic-injections-2026 2026-09-29T22:10:34+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Curia New York Receives FDA Warning Letter Over Thousands of Undocumented Chromatographic Injections https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a94eb630-0fb9-4ccc-91db-bb927560961f/daf6dc40-76d2-4ef1-a31d-c2f72052761b.png https://www.pharmanow.live/latest-news/ab-science-revises-clinical-trial-timelines-for-cause-gcp-inspection 2026-09-29T18:44:13+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Ab Science Revises Trial Timelines After Three Gcp Inspections Ab Science https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ab-science-cause-gcp-inspection-clinical-trial-timelines-202620260929184005.webp https://www.pharmanow.live/latest-news/novo-nordisk-hengrui-pharma-license-hrs-1596-oral-glp1-gip-agonist 2026-09-29T18:32:53+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Novo Nordisk Signs $2.6B Deal With Hengrui For Oral GLP-1 Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-hengrui-pharma-hrs-1596-oral-glp1-gip-agonist20260929183200.webp https://www.pharmanow.live/latest-news/teva-fda-approval-degevma-denosumab-biosimilar-xgeva 2026-09-29T18:25:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Teva Wins FDA Nod For DEGEVMA, Completing Denosumab Portfolio Teva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/teva-fda-approval-degevma-denosumab-biosimilar-xgeva20260929182504.webp https://www.pharmanow.live/latest-news/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-2026 2026-09-29T18:21:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 FDA Warns Boothwyn Pharmacy Over Sterility, Potency Issues FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-202620260929182105.webp https://www.pharmanow.live/latest-news/oryzon-ema-cta-vafidemstat-hope-2-phelan-mcdermid-syndrome 2026-09-29T10:41:54+05:30 Pharma Now en 2026-09-28T00:00:00+05:30 Oryzon Gains Ema Cta For Vafidemstat Phase Ii Pms Study Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-genomics-vafidemstat-hope-2-phelan-mcdermid-syndrome-202620260929103927.webp https://www.pharmanow.live/latest-news/inventiva-nativ3-phase-3-topline-results-lanifibranor-mash-2026 2026-09-29T10:36:25+05:30 Pharma Now en 2026-09-28T00:00:00+05:30 Inventiva Awaits Phase 3 Nativ3 Data For Lanifibranor Inventiva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/inventiva-nativ3-phase-3-lanifibranor-mash-results-202620260929103452.webp